Meet the 2020 Integrative Team
Dr. Andrew Lazootin
|
Robert Slovak
|
Jere Rivera-Dugenio, Ph.D.
|
Francisco Coll Sanchez |
Dr. Isso Kimura, DDS, PhD |
Dr. Isabel Silvestre, Ph.D. |
Robert Slovak - Mechanical and Astronautical Engineer, Robert Slovak has over 30 years of experience in the water treatment industry, specializing in membrane separation technology and products. His career included a “significant contribution” to the POU (Point-of-Use) and commercial/institutional RO (Reverse Osmosis) industry, especially in the area of system design, application knowledge, and technical training. He is an expert in water and molecular hydrogen therapy (www.purative.com)
Jere Rivera-Dugenio, Ph.D. - Jere is a Doctor of Natural Medicine and Quantum Morphogenetic Physics expert specializing in Autism Spectrum Disorder and Cancer. He received his Ph.D. in Natural Medicine from the International Quantum University for Integrative Medicine in Honolulu, Hawaii. Jere specializes in advanced morphogenetic scalar plasma sound technologies for patients with cancer and autism. He has lectured and presented his research findings at The BioRegenesis Conference, The Conference on Physics, Chemistry and Biology of Water, The Best Answer for Cancer Conferences and Autism One. Jere is the founder and CEO of Quantum Spanner, LLC Jere specializes in Rivera-Dugenio is the founder and CEO of Quantum Spanner, LLC. He is also co-owner of Bridgeway Senior Care Center in Bridgewater, NJ.
Rey Carungcong -Rey Carungcong brings his impeccable educational and clinical background in Psychology, ABA, and Music Therapy while working with individuals with special needs since 1995. Rey majored in Music Therapy with a minor in Psychology. Working as a Certified Music Therapist, as well as a Behavioral Therapist, Rey gained extensive experience in the Mental Health Field. Rey has a combined total of over 30 years in the field of sound therapy and energy healing. He also developed a unique Experiential Therapy program, Surf Therapy, that utilizes and blends the modalities and theories of Neurophysiology, Kinesiology, Applied Behavioral Analysis, Sensory Integration Theory, Cognitive Development Theory, and Social Development Theory.
Francisco Coll Sanchez - Since 2002, Francisco is the CEO of Quinton Laboratoires. He has been working in all areas of the company, as sales, marketing and, the last years, has actively participated in the creation of a R&D department. Francisco's trajectory has been recognized with several awards during his career. Currently, he is more involved in the divulgation of the Marine Therapy, through seminars addressed to health professionals such as doctors, pharmacists or naturopaths. From Japan, China and Malaysia to Spain, France, Italy and the United Kingdom, even in the United States, Francisco has shared the benefits of Quinton Marine Therapy.
Dr. Andrew Lazootin, N.D. - Dr. Andrew now semi retired, has clients around the globe with clinics in Australia and New Zealand. His extensive training in over 14 modalities from Tibetan medicine to stem cell and peptide therapies give him a truly holistic approach to treating his patients. Andrews experience and willingness to share and train practitioners and his clients in maximizing their outcomes toward their journey to health make him much sought after and loved. Experienced in everything from Sanum and Heel biologics to stem cell therapies, rife and meditation Andrew leaves no stone unturned in his treatments. His wealth of knowledge and willingness to share makes him a sought after commodity by doctors around the world. Andrew Lazootin ND is a purveyor of information to the common man.
Isabel Silvestre, Ph.D., received a Bachelor of Science degree from the University of Lisbon, Portugal and received her Ph.D. from the University of Porto, Portugal and University of Nevada, Reno School of Medicine. After completing a post-doctoral fellowship in cancer immunology at the University of Nevada, Reno, she joined as faculty in 2008. In 2013 and 2014, Dr. Silvestre served as the scientific director of Simmaron Research, Inc., a non-profit foundation that has a mission to benefit patients with neuroimmune diseases, and as a scientist to The Edward P. Evans Foundation, NY. She has more than 18 years of experience studying the biology of NK cells and other immune cells and their applications in pre-clinical and clinical immunotherapy with peer-reviewed publications.
Jere Rivera-Dugenio, Ph.D. - Jere is a Doctor of Natural Medicine and Quantum Morphogenetic Physics expert specializing in Autism Spectrum Disorder and Cancer. He received his Ph.D. in Natural Medicine from the International Quantum University for Integrative Medicine in Honolulu, Hawaii. Jere specializes in advanced morphogenetic scalar plasma sound technologies for patients with cancer and autism. He has lectured and presented his research findings at The BioRegenesis Conference, The Conference on Physics, Chemistry and Biology of Water, The Best Answer for Cancer Conferences and Autism One. Jere is the founder and CEO of Quantum Spanner, LLC Jere specializes in Rivera-Dugenio is the founder and CEO of Quantum Spanner, LLC. He is also co-owner of Bridgeway Senior Care Center in Bridgewater, NJ.
Rey Carungcong -Rey Carungcong brings his impeccable educational and clinical background in Psychology, ABA, and Music Therapy while working with individuals with special needs since 1995. Rey majored in Music Therapy with a minor in Psychology. Working as a Certified Music Therapist, as well as a Behavioral Therapist, Rey gained extensive experience in the Mental Health Field. Rey has a combined total of over 30 years in the field of sound therapy and energy healing. He also developed a unique Experiential Therapy program, Surf Therapy, that utilizes and blends the modalities and theories of Neurophysiology, Kinesiology, Applied Behavioral Analysis, Sensory Integration Theory, Cognitive Development Theory, and Social Development Theory.
Francisco Coll Sanchez - Since 2002, Francisco is the CEO of Quinton Laboratoires. He has been working in all areas of the company, as sales, marketing and, the last years, has actively participated in the creation of a R&D department. Francisco's trajectory has been recognized with several awards during his career. Currently, he is more involved in the divulgation of the Marine Therapy, through seminars addressed to health professionals such as doctors, pharmacists or naturopaths. From Japan, China and Malaysia to Spain, France, Italy and the United Kingdom, even in the United States, Francisco has shared the benefits of Quinton Marine Therapy.
Dr. Andrew Lazootin, N.D. - Dr. Andrew now semi retired, has clients around the globe with clinics in Australia and New Zealand. His extensive training in over 14 modalities from Tibetan medicine to stem cell and peptide therapies give him a truly holistic approach to treating his patients. Andrews experience and willingness to share and train practitioners and his clients in maximizing their outcomes toward their journey to health make him much sought after and loved. Experienced in everything from Sanum and Heel biologics to stem cell therapies, rife and meditation Andrew leaves no stone unturned in his treatments. His wealth of knowledge and willingness to share makes him a sought after commodity by doctors around the world. Andrew Lazootin ND is a purveyor of information to the common man.
Isabel Silvestre, Ph.D., received a Bachelor of Science degree from the University of Lisbon, Portugal and received her Ph.D. from the University of Porto, Portugal and University of Nevada, Reno School of Medicine. After completing a post-doctoral fellowship in cancer immunology at the University of Nevada, Reno, she joined as faculty in 2008. In 2013 and 2014, Dr. Silvestre served as the scientific director of Simmaron Research, Inc., a non-profit foundation that has a mission to benefit patients with neuroimmune diseases, and as a scientist to The Edward P. Evans Foundation, NY. She has more than 18 years of experience studying the biology of NK cells and other immune cells and their applications in pre-clinical and clinical immunotherapy with peer-reviewed publications.
Summaries of past missions:
For the 2019 mission, the Integrated Medicine and Medical team assessed and treated over 426 patients in four days.
For the 2018 Integrative Medicine Mission, the GC Rivera Foundation partnered with FCTI and Original Quinton and saw over fifty (50) special needs cases from ASD to MS to deaf, blind children.
The 2017 February Integrative Medicine Mission in the Philippines offered medical and surgical procedures but also featured the Gerald Anderson Foundation's autism dog therapy for children with autism spectrum disorder (ASD), holistic nutritional and glyphosate training for the doctors in the Philippines. We also utilized some of the most advanced, energy medicine devices and nutraceuticals on this mission to help the underprivileged people.
During the 2016 mission in the Philippines, Jere and Robert discovered that over 80% of the children with ASD had been exposed to the herbicide "glyphosate", which is a broad-spectrum systemic herbicide and crop desiccant. It is an organophosphorus compound, specifically a phosphonate. It is used to kill weeds, especially annual broadleaf weeds and grasses that compete with crops. It was discovered to be an herbicide by Monsanto chemist John E. Franz in 1970. Monsanto brought it to market in 1974 under the trade name Roundup, and Monsanto's last commercially relevant United States patent expired in 2000.
Farmers quickly adopted glyphosate, especially after Monsanto introduced glyphosate-resistant Roundup Ready crops, enabling farmers to kill weeds without killing their crops. In 2007, glyphosate was the most used herbicide in the United States' agricultural sector and the second-most used in home and garden, government and industry, and commerce. By 2016 there was a 100-fold increase in the frequency of applications and volumes of glyphosate-based herbicides (GBHs) applied, partly in response to the unprecedented global emergence and spread of glyphosate-resistant weeds. Dr. Stephanie Seneff, research scientist from the Massachusetts Institute of Technology (MIT), made a dire prediction during an event sponsored by the Groton Wellness organization. She said, "At today's rate, by 2025, one in two children will be autistic. Seneff was leading a presentation that showed a strong correlation between the increased use of Roundup starting in the early 1990's and the rising number of autism diagnoses over the past three decades. In 1975, 1 in 5,000 children were diagnosed with autism. The current rate is 1 in 68, and it shows no sign of slowing down.